Sperling Prostate Center

Month: March 2020

3 Areas in which mpMRI Wins 1st Prize After Prostate Cancer Treatment

Prostate MRI vs Biopsy - Sperling Prostate Center
No one can dispute the superiority of multiparametric MRI (mpMRI) over transrectal ultrasound (TRUS) for detecting and characterizing prostate cancer (PCa) before biopsy and treatment. The past five years alone have seen a rapid accumulation of research evidence that mpMRI makes it possible to save medical dollars by avoiding unnecessary biopsies and their risks. While keep reading

FDA Vetoes Photodynamic/TOOKAD Focal Therapy for Prostate Cancer

Miomolecular MRI Imaging - Sperling Prostate Center
The often-quoted “Hope springs eternal in the human breast” was penned by the 18th century poet Alexander Pope. It certainly to developing new approaches to conquering prostate cancer (PCa). The greatest challenge to optimism may be the situation of men with metastatic castration-resistant PCa who hope for a breakthrough lifesaving cure while experimental immunotherapies and keep reading

This content is solely for informational purposes and does not substitute for diagnostic or medical advice. Talk to your doctor or contact us if you have questions or concerns of a personal, medical nature. This site uses cookies to analyze traffic and user behavior, protect your privacy, and provide you with the best user experience. Learn more. 
An update on COVID-19: Your health and safety are our top priority.
Learn More
WordPress Image Lightbox